Skip to content

SPARK THERAPEUTICS, INC.

CIK 0001609351

← back to feed
Revenue (TTM)
$67.43M
+22.9% YoY Q3 Nov 2019
Net Income (TTM)
−$232.55M
−37.8% YoY Q3 Nov 2019
EPS Diluted (TTM)
−$1.73
−37.3% YoY Q3 Nov 2019
Gross Margin
99.1%
Q3 Nov 2019
Operating Margin
-361.4%
Q3 Nov 2019
Net Margin
-344.9%
Q3 Nov 2019
Free Cash Flow (TTM)
−$85.7M
Q3 Nov 2019
Cash
$207.14M
Q3 Nov 2019
Total Debt
$49.17M
Q3 Nov 2019
Shares Outstanding
38.52M sh
Q3 Nov 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings